USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-12 обновлены отчеты компании ANIX: 2023-Q42023-Q32022-Q4
Anixa Biosciences logo
Anixa Biosciences ANIX
$ 3.0 -2.91%

Anixa Biosciences Мультипликаторы 2011-2024 | ANIX

Мультипликаторы по годам Anixa Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.0 -0.0 -4.6 -5.8 -6.5 -4.9 -6.1 -10.9 -19.6 -4.2 -4.5 -9.4 -3.2

P/S

0.7 - 117.4 - 303.2 62.1 84.1 182.4 2.9 11.1 116.7 42.2 23.8

EPS

0.3 0.5 -0.5 -0.5 -0.6 -0.8 -0.6 -0.6 -16 -1.1 -0.1 -0.0 -0.0

EV (Enterprise Value)

1.39 млн -10 млн 32.5 млн 53 млн 73.8 млн 67.3 млн 28 млн 56.9 млн 27 млн 42.4 млн 53.2 млн 46.4 млн 30.6 млн

EBITDA per Share

-355 -457 -0.44 -0.447 -0.558 -0.759 -0.471 -0.436 -0.0644 -0.494 -0.916 -0.517 -0.685

EV/EBITDA

-2.2 -5.3 -6.5 -4.9 -4.7 -12.5 -36.6 -7.9 -6.3 -9.6 -4.6

PEG

-0.0 -0.0 -1.09 -0.25 -0.26 0.14 0.52 0.04 -0.23 -0.21 0.03 -0.19 0.1

P/B

0.0 0.0 1.7 7.1 15.7 13.3 3.8 55.4 5.4 10.1 -13.7 -33.4 22.5

P/CF

-0.0 -0.0 -12.2 2435.1 -15.4 -16.0 -8.0 -15.5 20.7 -17.1 -14.2 -12.7 -32.9

ROE %

-40.31 -46.80 -36.55 -122.12 -242.02 -270.01 -63.22 -508.01 -27.29 -239.58 303.56 356.16 -697.34

ROA %

-38.44 -44.70 -35.73 -106.76 -185.06 -217.04 -56.84 -89.13 -14.77 -106.08 -185.31 -75.13 -85.34

ROCE %

-45.24 -47.77 -37.07 -120.74 -238.37 -264.42 -76.68 -87.39 -10.81 -69.61 -355.37 -107.72 -76.88

Current Ratio

11.9 13.7 24.3 7.9 4.1 4.4 7.9 7.3 11.6 3.5 0.4 0.5 1.5

DSO

274.6 - - - 97.1 - - - - 39.8 164.3 - -

DIO

- - - - - - - - - - - - -

DPO

- - - - 1286.2 276.5 1676.8 787.0 37.5 99.2 607.7 28698.9 4012.9

Операционный цикл

274.6 - - - 97.1 - - - - 39.8 164.3 - -

Финансовый цикл

274.6 - - - -1189.0 -276.5 -1676.8 -787.0 -37.5 -59.4 -443.4 -28698.9 -4012.9

Все данные представлены в валюте USD

Мультипликаторы поквартально Anixa Biosciences

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.1 - -0.08 -0.07 0.08 -0.33 -0.09 -0.12 -0.09 -0.32 -0.14 -0.08 -0.13 -0.36 -0.11 -0.12 -0.25 -0.49 -0.11 -0.13 -0.11 -0.5 -0.3 -0.08 -0.41 -0.47 -0.12 0.02 -0.18 -0.45 -0.13 -0.15 0.43 -0.01 -0.18 -0.26 -0.02 -0.75 0.05 -0.02 -0.01 -0.04 -0.01 -0.01 - -0.01 - - -0.01 -0.02 -0.01 -0.01

EBITDA per Share

- - - - -82.7 -0.33 -91.8 -0.12 -0.09 -0.3 -0.14 -0.09 -0.13 -0.36 -0.1 -0.13 -0.26 -0.5 -0.11 -0.13 -0.11 -0.51 -0.3 -0.08 -0.16 -0.39 -0.12 -0.12 -0.17 -0.41 -0.11 -0.12 0.44 0.05 -0.16 -0.23 -0.01 -0.38 -0.01 -0.01 -0.01 -0.03 -0.01 -0.01 - -0.01 - - - -0.02 -0.01 -0.01

ROE %

-41.44 -27.00 -61.84 -60.88 -63.63 -71.24 -61.63 -64.84 -60.32 -91.70 -155.44 -172.59 -195.95 -238.98 -332.61 -344.25 -363.30 -301.22 -281.49 -341.39 -317.57 -194.78 -72.60 5.53 32.92 -105.67 -466.89 -556.02 -686.85 -597.05 -196.85 -116.78 -32.24 -13.92 -173.15 -131.19 -167.98 -73.50 302.86 370.37 525.99 247.68 188.07 163.01 161.88 18.13 -401.51 -621.82 -553.09 -263.83 -167.62 -121.64

ROA %

-40.01 -24.33 -57.60 -56.59 -59.10 -67.63 -59.02 -62.28 -58.09 -70.40 -128.19 -143.60 -164.91 -214.24 -283.68 -290.58 -303.57 -251.35 -236.72 -287.65 -268.11 -328.87 -228.18 -163.61 -140.41 -73.54 -107.48 -106.73 -131.15 -84.45 -14.86 -12.41 -13.77 -77.05 -147.38 -125.68 -137.60 -130.46 -190.70 -242.71 -252.35 -235.53 -136.89 -100.54 -70.51 -91.76 -91.18 -100.58 -67.68 -32.29 -20.51 -14.89

ROCE %

-46.50 -30.19 -65.53 -63.44 -65.32 -72.24 -62.46 -65.65 -61.10 -92.98 -155.71 -171.28 -194.88 -237.53 -335.68 -349.61 -368.66 -306.84 -283.80 -345.22 -321.47 -255.81 -147.14 -65.84 -55.37 -132.90 -442.28 -519.16 -620.15 -532.45 -163.71 -94.48 -20.40 -32.45 -123.84 -98.32 -89.91 31.99 303.75 374.55 464.09 187.31 204.06 191.12 208.93 -50.92 -632.73 -800.75 -615.91 -380.08 -114.14 -121.69

Current Ratio

14.3 11.9 13.3 16.4 17.6 13.8 19.7 23.6 - 24.3 - 24.3 8.1 8.0 7.7 8.6 - 4.2 4.2 4.2 - - - - 0.5 9.9 3.0 2.4 1.7 1.2 1.2 1.2 2.6 2.2 2.2 2.2 - 1.8 1.8 1.8 - 0.6 - - - - - - - - - -

DSO

- - - 55.6 4.2 - - - - - - - - - - - - 24.3 24.3 12.1 - 25.2 38.6 - - 27.8 27.8 - - - - - 0.2 - - - - 15.9 30.7 16.5 3748.5 - - - 0.7 912.5 - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.5 1.4 -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 46.7 - - 12.1 31.2 -

Операционный цикл

- - - 55.6 4.2 - - - - - - - - - - - - 24.3 24.3 12.1 - 25.2 38.6 - - 27.8 27.8 - - - - - 0.2 - - - - 15.9 30.7 16.5 3748.5 - - - 0.7 912.5 - - - 0.5 1.4 -

Финансовый цикл

- - - 55.6 4.2 - - - - - - - - - - - - 24.3 24.3 12.1 - 25.2 38.6 - - 27.8 27.8 - - - - - 0.2 - - - - 15.9 30.7 16.5 3748.5 - - - 0.7 912.5 -46.7 - - -11.5 -29.9 -

Все данные представлены в валюте USD